We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Automated Workflow Offers PCR-Based Molecular Diagnostic Assay Menu

By LabMedica International staff writers
Posted on 01 Sep 2010
A novel, integrated system sets new standards for molecular testing and incorporates all workflow steps from sample to detection.

The system offers features that create flexibility, such as continuous loading, random access, open channels for user-developed tests, and a very broad menu of commercial assays. More...
It has the ability to process an almost unlimited range of sample types and it should transform the laboratory's work in the emerging field of molecular diagnostic

This new and complete workflow solution is comprised of modules that can be used as standalone systems or combined into a fully integrated system. Called QIAsymphony RGQ, and introduced by Qiagen (Frankfurt, Germany), the system comprises the physical and data integration of the modules QIAsymphony SP for sample preparation, QIAsymphony AS for assay setup, and the Rotor-Gene Q real time polymerase chain reaction (PCR) thermocycler.

QIAsymphony provides the broadest available PCR-based assay menu, including the Artus real time PCR kits for the detection of human immunosuppression virus (HIV), Human hepatitis C and B viruses (HCV, HBV), and a transplantation panel with Cytomegalovirus (CMV), Epstein Bar virus (EBV), Herpes simplex virus (HSV), Varicella-Zoster (VZV) and BK virus (BKV1). (BK was the initials of the patient from whom the virus was first isolated).

A large pipeline of more tests will be launched in the coming months, including TheraScreen, epidermal growth factor receptor (EGFR), KRAS, as well as Artus Influenza, Computed tomography (CT), CT Neisseria gonorrhoeae (CT/Ng) and an extended transplantation panel. Many more tests are in development including integration of detection options such as pyrosequencing and multiplexing solutions.

Qiagen N.V., a Netherlands holding company, is a global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA, and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated bio-molecules visible.

Related Links:
Qiagen



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.